Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Decoding Peptide-Mediated mRNA Decay: Uncovering the Role of Nascent Polypeptides in Gene Regulation

Project description

A new mechanism of protein homeostasis

Cells constantly adjust the stability of their mRNAs to fine-tune protein production. While classical pathways rely on RNA-binding factors, a newly uncovered mechanism called peptide-mediated mRNA decay (PMD) links mRNA degradation directly to the nascent protein being synthesised. This process ensures that excess protein triggers selective destruction of its own transcript via factors that recognise the emerging polypeptide. Defects in PMD can disrupt cell division and neurodevelopment, and early evidence suggests it may also regulate transcripts encoding aggregation-prone proteins. The ERC-funded DECODE-PMD project will decipher how nascent peptides initiate decay. The identification of physiological triggers and PMD targets genome-wide will help establish a new paradigm for protein homeostasis.

Objective

Cells tightly regulate mRNA stability to ensure accurate gene expression across diverse cellular states and conditions. Traditionally, selective mRNA degradation has been attributed to the recognition of nucleotide sequence elements by proteins or small RNAs that subsequently recruit decay factors. Conversely, an emerging mechanism termed “peptide-mediated mRNA decay” (PMD) involves the encoded protein: my postdoctoral work revealed how the nascent polypeptide—physically linked to the mRNA during translation by the ribosome—can direct mRNA decay. This process is exemplified by tubulin mRNAs, which are selectively degraded when cells sense excess free tubulin levels. In this novel type of regulation, a recognition factor binds the nascent polypeptide to recruit downstream factors that trigger mRNA degradation. Impaired tubulin PMD results in severe phenotypes like defects in cell division and neurodevelopment. Beyond tubulins, emerging evidence points to critical PMD mechanisms targeting transcripts encoding aggregation-prone proteins. I postulate that PMD represents an entirely unexplored paradigm of gene regulation that dynamically adjusts protein production to ensure cellular fitness. However, the mechanistic understanding of PMD is still limited and the full range of substrates remains unknown.
In DECODE-PMD I will unravel how nascent polypeptides direct mRNA degradation on ribosomes and chart the transcriptome-wide map of PMD substrates. Specifically, I aim to (1) decode how mRNA translation and degradation are coupled during tubulin PMD using a biochemical reconstitution approach; (2) decipher the physiological triggers of tubulin PMD and its regulation; and (3) harness advanced sequencing methods to systematically identify PMD substrates and derive common mechanistic principles. Our innovative work will provide a conceptual framework for how cells exploit nascent polypeptide recognition for selective tuning of mRNA stability to maintain protein homeostasis.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

FUNDACIO CENTRE DE REGULACIO GENOMICA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 1 703 070,00
Address
CARRER DOCTOR AIGUADER 88
08003 Barcelona
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 1 703 070,00

Beneficiaries (1)

My booklet 0 0